Dr McGoldrick continues to reflect on the information provided by Karen and discusses the tests he would like to conduct.
Dr Rebecca Leon discusses improved detection with Prof. Gordon Jayson.
Prof. Gordon Jayson and Dr Rebecca Leon discuss the reliability of CA125 in diagnosing ovarian cancer.
Please note: Prof. Gordon Jayson recommends that CA125 is not a good screening tool for the asymptomatic patient and should not be used in screening the general population.
*Arranging a transvaginal ultrasound is the gold standard, but if this is not possible, organise an ultrasound of the abdomen and pelvis as per NICE guidelines.
Summary of Karen’s condition: Karen’s CA125 showed a raised level of 90 and an ultrasound showing stage 3 ovarian cancer. Karen was referred to a specialist to discuss treatment options. It is important that the GP safety nets and provides
clear guidance if a patient’s condition remains the same, progresses or persists.
Link: Ovarian cancer: recognition and initial management, NICE (2011)
Link: Suspected cancer: recognition and referral, NICE (2020)
Link: Ovarian Cancer Action guide for primary care, Ovarian Cancer Action (2019)
Link: Diagnostic tests for ovarian cancer: A guide for primary care, Target Ovarian Cancer (2019)